$AUROPHARMA

Aurobindo Pharma Limited COMPLETES ACQUISITION OF LANNETT IN THE US • Wholly owned subsidiary Aurobindo Pharma USA Inc. has completed acquisition of Lannett Company Inc. • Deal closed post approval from U.S. Federal Trade Commission; effective June 29, 2026 • Lannett to operate as “Lannett Company LLC” under Aurobindo Pharma USA • Integration to focus on uninterrupted medicine supply, partner continuity, and employee transition (400+ employees onboarded) • Strengthens presence in US generics market and expands product portfolio Impact: Positive, as acquisition enhances US market footprint and supports long-term growth in generics business.